Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
David Meeker
Pharma
Rhythm scores first FDA nod for rare genetic-defect obesity med
With its new FDA approval for Imcivree, Rhythm Pharmaceuticals is entering a new field of treating obesity by targeting genetic defects.
Eric Sagonowsky
Nov 30, 2020 3:37am
NICE backflips on Sanofi's Gaucher med Cerdelga
Jun 1, 2017 9:32am
Sanofi Genzyme chief Meeker bows out, Sibold steps in
Apr 5, 2017 9:45am
